Physicians and clinical trials. to avoid federal scrutiny, take care when determining fair market value
Morillo, A.
Modern Healthcare 43(38): 22
2013
ISSN/ISBN: 0160-7480 PMID: 24340738 Document Number: 666136
Document emailed within 1 workday
Related Documents
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570Holmgren, P.G. 2003: Why does the SaluAnsvar avoid scrutiny? Lakartidningen 100(19): 1732
Schoenfeldt, M.; Trimble, E.L.; Denicoff, A.M.; O'Mara, A. 2003: Clinical trials referral resource. Current clinical trials of supportive care/palliative care Oncology 17(11): 1578; 1583-1585; 1589-1590
Anonymous 1977: Notes prepared by the Federal Ministry for Agriculture and Forestry Federal Republic of Germany. (a) remarks concerning the Meat Market Policy in the Federal Republic of Germany. (b) Quality Criteria in the Beef Sector. (c) Comments on the contribution by Mr. R. Borst Alternative to Price Finding for slaughter animals on organised markets OECD: Towards a more efficient beef chain Documentation assembled for the symposium organised by the OECD in Paris from 10th-13th January 1977: 553-560
Anonymous 1977: Notes prepared by the Federal Ministry for Agriculture and Forestry Federal Republic of Germany. (a) remarks concerning the Meat Market Policy in the Federal Republic of Germany. (b) Quality Criteria in the Beef Sector. (c) Comments on the contribution by Mr. R. Borst Alternative to Price Finding for slaughter animals on organised markets OECD: Towards a more efficient beef chain Documentation assembled for the symposium organised by the OECD in Paris from 10th-13th January 1977: 553-560
Anonymous 1977: Notes prepared by the Federal Ministry for Agriculture and Forestry Federal Republic of Germany. (a) remarks concerning the Meat Market Policy in the Federal Republic of Germany. (b) Quality Criteria in the Beef Sector. (c) Comments on the contribution by Mr. R. Borst Alternative to Price Finding for slaughter animals on organised markets OECD: Towards a more efficient beef chain Documentation assembled for the symposium organised by the OECD in Paris from 10th-13th January 1977: 553-560
Anonymous 1977: Notes prepared by the Federal Ministry for Agriculture and Forestry Federal Republic of Germany. (a) remarks concerning the Meat Market Policy in the Federal Republic of Germany. (b) Quality Criteria in the Beef Sector. (c) Comments on the contribution by Mr. R. Borst Alternative to Price Finding for slaughter animals on organised markets OECD: Towards a more efficient beef chain Documentation assembled for the symposium organised by the OECD in Paris from 10th-13th January 1977: 553-560
Benko, L.B. 2004: Play fair. Ark. AG accuses Blues of monopolizing local market Modern Healthcare 34(3): 18-19
Martynenko, A.V. 2000: Patients with sexually transmitted diseases and the physicians delivering care as elements in the medical services market Likars'ka Sprava 2000(3-4): 107-109
Hallam, K. 1999: Columbia gets tax breaks. Company wins in challenges of fair market value of Virginia hospitals Modern Healthcare 29(33): 6
Lundberg, G.D. 2004: Should the unpublished results of clinical trials be available to other researchers and physicians? Medgenmed: Medscape General Medicine 6(3): 35
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Frayne, S.M.; Mancuso, M.; Prout, M.N.; Freund, K.M. 2001: Attitudes of primary care physicians toward cancer-prevention trials: a focus group analysis Journal of the National Medical Association 93(11): 450-457
Nitz, U.; Frick, M.; Adomeit, A.; Jackisch, C.; Schwenkhagen, A.; Möbus, V.; Bender, H.G. 1997: Significance of stem cell-supported high-dose chemotherapy in the treatment of gynecological malignancies: indications and current clinical trials in the Federal Republic of Germany Zentralblatt für Gynakologie 119(5): 195-203
Whitten, B.H. 2010: Peer grouping must be fair to physicians Minnesota Medicine 93(6): 19
Wamai, R.G.; Morris, B.J.; Waskett, J.H.; Green, E.C.; Banerjee, J.; Bailey, R.C.; Klausner, J.D.; Sokal, D.C.; Hankins, C.A. 2012: Criticisms of African trials fail to withstand scrutiny: male circumcision does prevent HIV infection Journal of Law and Medicine 20(1): 93-123
Woods, D. 1979: Ontario family physicians seek excellence, fair remuneration and recognition Canadian Medical Association Journal 121(11): 1526; 1530
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Duncan, L.R.; Latimer, A.E.; Pomery, E.; Rivers, S.E.; Berotoli, M.C.; Salovey, P. 2013: Testing messages to encourage discussion of clinical trials among cancer survivors and their physicians: examining monitoring style and message detail Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 28(1): 119-126
Thompson, H.A. 1992: Physicians can avoid penalties by posting required safety signs Texas Medicine 88(9): 51-52